Long-term consolidation has been broken down. The company's financial performance leaves much to be desired. The target levels of the downtrend can be the long-term support levels of 21.85, 4.70.
Don't forget upcoming catalysts though of phase 3 trial results. I am closely following this one and plan to buy shares down as far as it will drop. What is your position?
Gelium
⋅
@aaronsmth5, If by the end of the year there are no test results and the general trend of stock indices is downtrend, then the company's shares have a good chance of continuing the downtrend. My position is to buy put options and watch developments. If the price with a gap rises on good news from the company, then I am wrong and the put options will have to be sold at a loss.